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Intracerebral hemorrhage (ICH) frequently results in severe disabilities and high mortality. RGD-containing elastin-like polypeptide
(REP), a modified elastin-like polypeptide (ELP), is a thermally responsive biopolymer. REP has high affinity for cells and is known to show
non-immunotoxicity, -cytotoxicity, and -inflammatory responses. Here we found that administration of REP in the acute phase of the ICH rat
model reduced the hematoma volume, decreased the number of activated microglia, attenuated the expression of von Willebrand Factor
(vWF), and prevented the leakage of immunoglobulin G (IgG) into the cerebral parenchyma without any occlusion of intact microvessels.
Therefore, the present data suggest that REP treatment could be a novel therapeutic strategy for attenuating the acute phase of ICH.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
Key words: Intracerebral hemorrhage; Elastin-like polypeptide; Nanomaterial; RGD-containing elastin-like polypeptideIntracerebral hemorrhage (ICH) is one of the most fatal diseases
and it represents about 15% of all strokes worldwide.1 When
cerebral vessels are ruptured by a traumatic damage or an aneurysm,
the parenchyma surrounding the injured vessels is aggravated by the
high pressure induced by blood leakage, resulting in the damage of
the cerebral tissue. The neurological dysfunction is directly caused
by tissue destruction, increasing compression, and brain edema.2
Approximately 75% of all patients with a spontaneous onset of ICH
die or suffer from disabilities within a year, and mortality rates at
1 month account for 40% of all deaths.1,3,4 Althoughmany clinical
trials related to ICH have been run, there is a lack of novel
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and resilience that are necessary to sustain tissues construction such
as skin and blood vessels.5,6 Elastin-like polypeptide (ELP) is derived
from human tropoelastin and composed of poly (Val-Pro-Gly-
Xaa-Gly) pentapeptide, wherein Xaa can be any amino acid except
proline.6–9 ELP is non-cytotoxic, easilybiodegradable, andcanbeused
for several types such as hydrogel, microfiber, and cell sheet.10–15
The most remarkable characteristic of ELP is its thermo-
sensitive responsiveness. At a specific temperature called
transition temperature (Tt), ELP changes its own physical
properties. Above Tt, ELP becomes insoluble and assumes an
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ELP relies on its chemical similarity to human tropoelastin, (i.e.
an elastin precursor) and it is therefore highly suitable for living
cells. However, low cell adhesiveness of ELP and its lack of
biological function limit its application to cell growth.19
To circumvent these hurdles, the repetitive integrin-binding
ArgGlyAsp (RGD) peptide containing ELP (V140) fusion
protein, TGPG[VGRGD(VGVPG)6]20WPC, named REP, was
developed.7 REP is capable of promoting the adhesion and
proliferation of neuronal cells on a poorly adherent organic
scaffold.20 In the present study, we hypothesize that REP
scaffold plays a pivotal role in blocking a ruptured vessel and
reducing the volume of hematoma. Therefore, we predict that an
ICH-induced proinflammatory response, such as the activation
of resident microglia changing to M1 phenotype, can be
mitigated. In addition, damaged blood vessels may be repaired.21
To verify our prediction, we measured the volume of the
hematoma and we analyzed the inflammatory responses using
immunohistochemistry. Here we show that REP administration
reduces the volume of the hematoma, decreases the leakage of
IgG to the brain parenchyma, attenuates the activation of
microglia immune responses, and reduces the expression of von
Willebrand factor (vWF) following ICH.Methods
Animals
All animal care and surgical procedures were approved by the
Institutional Animal Care and Use Committee (IACUC) of the
Yonsei Laboratory Animal Research Center (YLARC).
Eight-week-old, male Sprague–Dawley (SD) rats (250-260 g)
were purchased from Orient (Gyeonggi-Do, Korea) and were
housed in a temperature- and humidity-controlled specific-pathogen
free (SPF) zone under a 12-h light–dark cycle.
Intracerebral hemorrhage (ICH) model
All rats were anesthetized with an intraperitoneal (i.p.)
injection of a mixture of zoletil (100 mg/kg, Virbac, USA) and
xylazine (rompun, 10 mg/kg, Bayer, Germany). Body temper-
ature of the rats was maintained at 36.5 °C-37.5 °C with heating
pads and it was monitored with rectal probes. The rats were
placed in a stereotactic apparatus, and a 30-gauge needle was
implanted into the striatum (anterior: 0.2 mm, lateral: 3 mm,
ventral: 6 mm). We then injected collagenase type VII (0.5 unit,
2 μL) for 10 min and the syringe was slowly (i.e. 10 min)
retracted from the skull. After the surgical procedure, the holes
were sealed with bone wax (Ethicon, USA).22–24
Preparation and characterization of REPand 5-carboxyfluorescein-
labeled REP (FAM-REP)
The necessary procedures of REP synthesis have been
previously reported.7 Briefly, the ELP was expressed and
purified in Escherichia coli BLR (DE3) by inverse transition
cycling. Contents of repetitive integrin-binding AspGlyAsp
(RGD) peptides and VG (VGVPG) domains were computed
using Compute pI/MW. The fusion protein (REP), which ispurified ELP (V140)-RGD peptide, was dissolved in cold PBS
(pH 7.2, Gibco, USA). To characterize the thermal transition, the
changes in temperature and absorbance at 350 nmwere monitored
withCaryWin-UV software. TheTt was defined as the temperature
at which 50% of the maximal turbidity was observed.
The preparation and characterization related with FAM-REP
have been previously described.10 In brief, to conjugate
5-carboxyfluorescein (FAM) to the N-terminus of REP,
5-carboxyfluorescein N-succinimidyl ester (5.0 μmol) in di-
methyl sulfoxide (580 μL) was added to REP (0.97 μmol) in
PBS (20 mL). The mixture was reacted at room temperature for
3 h to generate FAM-labeled REP. FAM-REP was purified by
performing 3 cycles of repeated inverse phase transition at 4 °C
for cooling and 45 °C for heating. The degree of FAM labelingwas
determined according to the protocol in the AnaTag™ protein
labeling kit (AnaSpec). The Tt is the temperature at which
solubilized REP forms highly hydrated hydrogel-like aggregates.
The inverse Tt of REP is determined by REP's concentration.
Jeon and colleagues reported that the transition curves of
three REP solutions were characterized in a dose-dependent
manner (20, 50, and 100 μM). When the temperature of the
solution was increased from 15 °C to 35 °C, all three solutions
exhibited an elevation in absorbance due to REP aggregation. Tt
values were determined to be 29.7, 25.9, and 25.3 °C for 20, 50,
and 100 μM REP, respectively. Because these Tt values were
lower than the mouse body temperature, the REP solutions
spontaneously self-assembled into gel-like aggregates after
topical loading into the injured space.10
Drug treatment
All rats were re-anesthetized 3 h after ICH and underwent an
incision on the neck along the midline. The right external carotid
artery (rECA) and the right common carotid artery (rCCA)
permanently tied with 4-0 silk sutures. After ligation of the
arteries, 100 μL of cold PBS (ICH + PBS group, n = 30) or an
equal volume of REP dissolved in cold PBS (ICH + REP group,
100 μM/100 μL, n = 40) were administered with an insulin
syringe through the right internal carotid artery (rICA).
Measurement of the hematoma volume
For the histological examination and the quantification of the
hematoma volume, rats were sacrificed 6, 24, or 48 h after ICH.
Rats were deeply anesthetized with an intraperitoneal (i.p.)
injection of a mixture of zoletil (100 mg/kg) and xylazine
(rompun, 10 mg/kg), transcardially perfused with PBS and 4%
paraformaldehyde in 0.1 mol/L phosphate-buffered saline. After
the cardiac perfusion, the brain was removed and sliced into
2 mm thick coronal sections. The percentage of hematoma
volume [(hematoma volume / hemispheric brain volume) × 100]
was measured using Image J.25
Immunohistochemistry
Fixed brain tissue was washed with PBS for 6 h and placed in
cryoprotectant (30% sucrose) for 3 days. The tissue was
embedded in OCT compound and transferred to −80 °C. Frozen
sections (n = 6, per group) were sliced into 10 μm thick section
and air dried at room temperature. For the immunofluorescence
Figure 1. Time-dependent changes of the percentage of the hematoma
volume following ICH. (A) Time-dependent changes of hematoma volume.
(B) The volume of hematoma significantly reduced in ICH + REP groups
compared to ICH-only, ICH + PBS, ICH + RGD, and ICH + ELP (V140)
groups (n = 7-8/group, *p b 0.05, **p b 0.01, ***p b 0.001, Tukey's
post-hoc test).
1855J. Park et al / Nanomedicine: Nanotechnology, Biology, and Medicine 13 (2017) 1853–1862analysis, the sections (n = 5, per group)were fixed in coldmethanol
for 15 min at−20 °C. After fixation, the sections were blockedwith
donkey serum (1:10) for 1 h at room temperature to avoid
non-specific binding. The following primary antibodies were used
overnight at 4 °C: polyclonal anti-rat IgG (1:50, Invitrogen,
Carlsbad, CA, USA) for the detection of IgG leakage in the
parenchyma, anti-Iba1 (1:200, Abcam, Cambridge, UK) for
detecting activated microglia, anti-PECAM (1:50, Santa Cruz,
Dallas, Texas, USA) for labeling endothelial cells (ECs), and
anti-vonWillebrand Factor (vWF, 1:200, Abcam, Cambridge, UK)
for ECs. The slides were washed in PBS three times and incubated
with the appropriate secondary antibodies conjugated either with
rhodamine (1:200, Millipore) or fluorescein isothiocyanate (FITC,
1:200, Millipore) for 1 h at room temperature in a dark chamber.
The slides were stained with 4,6-diamidino-2-phenylindole (DAPI,
Vector, Burlingame, USA) to counter-stain the nuclei and mounted
with cover slip. All images were acquired with a confocal
microscope (LSM700, Carl Zeiss, Thornwood, NY, USA).
2,3,5-triphenyl-2H-tetrazolium chloride (TTC) staining
Ratswere deeply anesthetized and injectedwithREP through the
intra-arterial route; namely, the right internal carotid artery (rICA).
Rats were euthanized 3, 6, and 24 h after the administration of REP.
The brains were removed and sliced into 2 mm-thick after cardiac
perfusion with PBS, and the sections were transferred to a 2% TTC
(Santa Cruz, Dallas, Texas, USA) solution at 37 °C for 20 min.
Cell adhesion assay
A 96-well plate was coated with REP at different concentra-
tions (0, 0.2, 0.6, 1.0 μM) and then incubated at 4 °C. After 12 h
of coating, excess REP was removed and wells were washed two
times with 200 μL PBS. Brain endothelial cells (b.End3 cell,
2 × 105 in 200 μL DMEM) were seeded in each well and
incubated for 1 h. After removing the culture medium, the wells
were washed quickly two times with 200 μL of cold PBS to
eliminate unattached cells. Subsequently, wells were treated with
200 μL of ice-cold 100%methanol at 25 °C for 10 min to fix the
cells. After fixation, the wells were rinsed three times with PBS
and 100 μL of crystal violet solution was added (0.5% w/v
crystal violet in 20% ethanol) and incubated for 20 min at 25 °C.
After incubation, the wells were washed three times with PBS to
remove excess crystal violet. Stained cells were recovered by
adding 200 μL of 100% methanol to each well, and gently
shaking the plate for 10 min at 25 °C. Finally, extracted crystal
violet was measured at 590 nm by using a microplate reader
(Multiskan, Thermoscienfic, USA).
Statistical analysis
All statistical analyses were performed using SPSS 18.0
software (IBM Corp., Armonk, NY, USA). Data were presented
as mean ± standard error of the mean (S.E.M). A one-way
repeated measures ANOVA was used to compare the differences
between experimental groups. The Tukey's post hoc multiple
comparison tests was used for further group comparisons.
Differences were considered statistically significant at p b 0.05
(*p b 0.05, **p b 0.01, *** p b 0.001).Results
Analysis of the hematoma volume following ICH
To evaluate the volume of the hematoma, different groups
of rats were sacrificed either 6, 24 or 48 h after the
collagenase-induced intracerebral hemorrhage (Figure 1, A).
The volume of the hematoma at the 6 h time point was
significantly reduced in the ICH + REP group (8.1%) as
compared to ICH-only (13.9%), ICH + PBS (13.2%),
ICH + RGD (10.1%), and ICH + ELP (V140) (9.3%) groups.
The percentage number represents the hematoma volume
[(hematoma volume / hemispheric brain volume) × 100].
However, no statistical difference was found between
ICH + ELP (V140) group and ICH + REP group at 6 h. Moreover,
hematoma volume of the ICH + REP group (6.0%) considerably
reduced, compared to ICH-only (15.4%), ICH + PBS (13.6%),
ICH + RGD (14%), and ICH + ELP (V140) (10.6%) groups 24 h
post-ICH. In addition, the level of hematoma gradually decreased in
the ICH + REP group (9.1%)when compared to ICH-only (16.7%),
ICH + PBS (13.7%), ICH + RGD (15.6%), and ICH + ELP
(V140) (13.9%) groups 48 h post-ICH. (Figure 1, B). Taken
together, the REP treatment reduces the hematoma volume
statistically significantly after collagenase-induced ICH injury.
Figure 2. Cell adhesion assay and observation of specifically targeted FAM-labeled REP following intracerebral hemorrhage (ICH). REP is located at the target
lesion at the ipsilateral site and enhances cell adhesion after injection. (A) Crystal violet-stained cells attached to plates coated with REP at different
concentrations. Images were taken 1 h after adhesion time. (B) Comparison of REP dose-dependent cell adhesion. (C) Fluorescence-tagged REP was
specifically observed in the ipsilateral site of the ICH + FAM-REP group (green). No fluorescence was observed in the ICH-only group (negative control) and
the contralateral site of the ICH + FAM-REP group. PECAM was used as an endothelial cell marker. Cell nuclei were stained with DAPI. (*p b 0.05,
**p b 0.01, ***p b 0.001, scale bar = 100 μm, Dunnett's multiple comparison test).
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REP location
During bleeding after traumatic injury, endothelial cells lining
the lumen of blood vessels are exposed. We hypothesized that
REP injected via rICA would adhere to endothelial cells.
Thus, the exposed lesion would be covered and filled with REP.
To investigate whether REP induces the adhesion of b.End3
cells, a cell adhesion assay using crystal violet was performed
(Figure 2, A and B). The b.End3 cells were seeded onto plates
dose-dependently coated with REP (0.2, 0.6, 1 μM). After 1 h
incubation, the percentage of attached cells in wells containing
REP was approximately 141%, 246%, and 334% relative to
control (0 μM, PBS). The b.End3 cells cultured on a 1 μM
REP-coated plate were approximately 2.3 times higher than on
control plates. Next, to confirm that REP administered via
arterial injection reached the target lesion, FAM-labeled REP
was injected into the rICA after ICH and the brain slices were
stained above Tt (25 °C) and inspected using a confocal
microscope. Because the major feature of REP is its ability to
undergo thermal-induced phase transitions, minor modifications
were made to the following procedures. We detected
FAM-tagged REP on the ipsilateral, but not on the contralateral
site of brains taken from the FAM-labeled REP group. FAM-like
fluorescence (i.e. a pseudo-positive signal) was not observed in
the ICH-only group. FAM-labeled REP changed its physical
property from liquid to gel-like aggregates upon in vivo
administration.10 Gel-like FAM-labeled REP could adhere to
the perihematomal cells and specifically blocked rupturedvessels (Figure 2, C). Therefore, our findings suggest that REP
promotes endothelial cell adhesion and is specifically located at
the lesion site. These data support our TTC staining results
indicating that REP treatment does not cause infarction of
healthy microvessels.
Relationship between obstruction of intact microvessels and
administration of REP
The 2,3,5-triphenyl-2H-tetrazolium chloride (TTC) staining
is generally used to assess cellular respiration so that
metabolically active and inactive tissues can be distinguished;
active tissue is stained with a deep red color, while the inactive
tissue is white. The TTC staining was used to confirm that the
injected REP aggregating into the right internal carotid artery
(rICA) specifically targets the lesion without occluding any other
intact microvessels. Three control rats were sacrificed at 3, 6 or
24 h after administration of REP without ICH (Cont + REP). No
ischemic infarction was observed upon REP administration in
groups (Figure 3). These results indicate that the
thermo-sensitive and reversible REP is biologically stable in
vivo by maintaining microvessels intact without infarction even
upon environmental changes.
Amount of the perivascular blood component IgG protein
leakage into parenchyma lesion after ICH
Based on the in vivo results showing the decreased hematoma
volume following the REP administration, we performed
immunohistochemistry to confirm the extent of IgG, a
Figure 3. 2,3,5-triphenyl-2H-tetrazolium chloride(TTC) staining. TTC
staining was performed 3, 6 and 24 h after administration of REP in normal
control (Cont). No ischemic infarction was found in Cont + REP groups.
(low magnification =10×, high magnification =20×, scale bar =2 mm).
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ruptured cerebral vessels to the parenchyma lesion in the
striatum. In ICH-only and ICH + PBS groups, IgG was highly
expressed compared to ICH + REP groups at all time points
(Figure 4, A-C); the relative percentage of IgG-positive area in
ICH + REP group (10.2%) was approximately less than half,
compared to ICH-only (20.7%) and ICH + PBS treated (20.3%)
groups at 6 h. Furthermore, the data showed that the extent of
IgG leakage in ICH + REP group (8.3%) was significantly
reduced compared with ICH-only (29.1%) and ICH + PBS
(25.0%) groups at 24 h post-ICH. Additionally, the relative
percentages of expression of IgG-positive area in ICH-only,
ICH + PBS and ICH + REP groups were approximately 23.5%,
20.5%, and 9.0%, respectively. These values were ~2 times
lower than those of ICH-only and ICH + PBS groups, at 48 h
post-ICH (Figure 4, D). These data indicate that REP blocks the
leakage of blood components from ruptured vessels to brain
parenchyma following ICH.
Alteration of the cerebrovascular integrity by the administration
of REP after ICH
To assess the cerebrovascular integrity, we performed an
immunohistochemistry using the anti-von Willebrand Factor
(vWF) antibody for detecting the damaged brain vessels and the
anti-platelet-endothelial cell adhesion molecule (PECAM)
antibody as a marker for blood vessels. vWF, a multimeric
glycoprotein, plays a crucial role in the coagulation system and it
is composed of multiple subunits produced by endothelial cells
and megakaryocytes. In addition, molecules of vWF are stored in
endothelial cells and in alpha-granules of platelets. vWF is
necessary for platelets to adhere to exposed subendothelial
collagen in arterioles. When bleeding caused by traumatic injury,
vWF provides receptor sites for platelet and collagen. The
primary receptor sites replace exposed subendothelial collagen
known as innermost vascular lining site, and bind a surface
receptor of platelet and glycoprotein Ib/IX/V.26,27 Then,
activated platelets adhere by binding vWF. The larger vWF
multimers form a fibrillar carpet on which the platelets assemble.The expression of vWF significantly increased in ICH-only and
ICH + PBS groups compared to Cont and ICH + REP groups
6 h after ICH (Figure 5, A and D). Moreover, vWF was highly
expressed in ICH-only and ICH + PBS groups compared to Cont
and ICH + REP groups 24 h after ICH (Figure 5, B and D).
Furthermore, vWF expression was substantially augmented in
ICH-only and ICH + PBS groups compared with Cont and
ICH + REP groups 48 h after, respectively (Figure 5, C and D).
These data indicate that REP enhances vessel integrity and
reduces the overexpression of vWF by replacing the role of vWF
filling the exposed subendothelial collagen site after ICH injury.
Microglial activation after ICH injury
Resident microglia interacting with neurons in the central
nervous system (CNS) exerts an important function similar to
macrophages fighting against viral, bacterial, and fungal
infections in periphery. The resident microglia changes to
activated forms that act as macrophages when they are stimulated
by molecular cues. Interestingly, microglia activation has been
considered detrimental for the treatment of many neurological
diseases.28–30 To detect the activated microglia following ICH,
we used the anti-ionized calcium binding adapter molecule 1
(Iba1) antibody which specifically detects activated microglia.31
To test whether the REP treatment on the traumatic brain
injury causes a negative effect like an immune response, we
performed an immunohistochemistry specific for active microg-
lia. We found that Iba1-positive cells were gradually increased in
all groups. The relative number of Iba1-positive cells, however,
significantly declined in ICH + REP groups compared to the
other groups. At 6 h, the percentage of Iba1-positive microglia in
the ICH-only, ICH + PBS and ICH + REP groups were 24.6%,
30.0%, and 9.3%, respectively (Figure 6, A and D). Moreover,
the number of Iba1-positive cells in the ICH + REP group was
significantly lower than the number of cells observed in the
ICH-only and ICH + PBS groups 24 h post-ICH. The percent-
ages of Iba1-positive cells were 11%, 36.3%, and 37.2% in the
ICH + REP, ICH-only and ICH + PBS groups, respectively
(Figure 3, B and D). Also, more Iba1-positive cells were
detected in both ICH-only (47.9%) and ICH + PBS (37.8%) than
in ICH + REP group (17.6%) 48 h post-ICH (Figure 6, C andD).
These data suggest that the administration of REP ameliorates
the activation of microglia that occur as an immune response
associated with the detrimental roles played by the post-ICH
activated microglia.Discussion
In the present study, the administration of REP reduced the
hematoma volume, prevented the leaking of the blood
component into the cerebroparenchyma, and attenuated the
migration of activated microglia to the perihematoma area. In
addition, vWF expression levels in the ICH + REP group were
significantly decreased compared to the other groups. These
results were related to the reduction of the ICH injury, including
the inflammatory responses. Previous findings showed that
biosynthesized extracellular matrix (ECM) obtained from animal
tissues have biological issues such as low adhesion, migration,
Figure 4. Percentage of positive-IgG area of the parenchyma lesion. (A-C) Immunohistochemistry showing the positive area of IgG in the brain parenchyma
lesion. (D) At all time points, IgG expression is significantly reduced in ICH + REP group relative to ICH-only and ICH + PBS groups. (n = 5/group,
*p b 0.05, **p b 0.01, ***p b 0.001, scale bar = 100 μm, Tukey's post-hoc test.)
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cells. Moreover, immunological response issues such as the
cytotoxicity had not been entirely resolved.7,32,33 Genetically
engineered biopolymers such as the ELP modeled by human
tropoelastin are considered novel biomaterials for the biomedical
fields. ELP has some promising properties for biological
applications: biocompatibility, biodegradability, and non-
immunogenicity. Above all, ELP reacts to thermal changes
through a soluble-insoluble phase transition. As a consequence,
ELP becomes a gel type above the Tt, and transition to a sol type
below Tt.
6,16–18,34–36 Several researchers have exploited this
ELP feature for drug and gene delivery in oncology.37–43 Although
an ELP with low immunotoxicity and cytotoxicity is highly
compatible with living cells and can be controlled at the gene
level, there are limitations in the ability of this compound to interact
with cells. Indeed, ELP shows reduced adhesive properties and
limited capability to sustain cell growth.19,36 In this study,
administration of ELP (V140) alone after ICH slightly but not
significantly reduced the volume of hematoma in time-dependent
manners. Particularly, the effect of ELP to reduce hematoma volume
could hardly be observed at 48 h after injury.
A newly biosynthesized extracellular matrix, named REP,
TGPG[VGRGD(VGVPG)6]20WPC fused with cell-adhesive
integrin Arg-Gly-Asp (RGD) ligands and elastin-derived
VGVPG pentapeptides has been reported recently.7,20,44 A
previous study showed that both the adhesion and proliferation
of neuronal progenitor cells (NPCs) were considerably
up-regulated by REP on a poorly adhesive organic scaffold.20
To improve the effect of ELP on ICH injury, ELP (V140)-based
recombinant biomaterial REP was used in the present study andwe investigated the effects of ELP (V140)-based recombinant
biomaterial REP after ICH. REP administration significantly
reduced the hematoma volume by 9.1%, compared to the results
in ICH-only (16.7%), ICH + PBS (13.7%), ICH + RGD
(15.6%), and ICH + ELP (V140, 13.9%) groups at the 48 h
time point after ICH injury. These findings may suggest that REP
treatment effectively reduces the hematoma volume after
collagenase-induced ICH injury. In addition, the amount of
IgG leakage following ICH was significantly decreased in the
ICH + REP group compared to ICH-only and ICH + PBS
groups. These results indicate that the injected thermo-sensitive
and solubilized REP may form self-assembled coacervates above
Tt and relocate to the hemorrhagic lesion, thereby covering the
ruptured cerebral vessels.
Moreover, the number of activated microglia within paren-
chyma was reduced in the ICH + REP group compared to
ICH-only and ICH + PBS groups.
The predominantly resident CNS macrophages, named
microglia, are known as immune cells related to the inflamma-
tory response. These cells transition to the activated form upon
the invasion of microbes or other molecular cues. Activated
microglia move to the hemorrhagic area by chemotaxis to
remove blood components and other debris.44–48 Therefore, our
findings indicate that REP induces hemostasis and prevents the
pressure-induced damage of peri-hematomal tissues caused by
blood components leaking from the injured vessels. Conse-
quently, the inflammatory response (i.e. the recruitment of
macrophages to the hemorrhagic lesion) is reduced.
Moreover, self-assembled REP injected into the brain did not
block any intact cerebral vessels in normal controls. Insufficient
Figure 5. Immunohistochemistry staining showing the time-dependent expression of vWF following ICH. (A-C) Immunohistochemistry for vWF. The
expression of vWF groups considerably reduced in ICH + REP relative to ICH-only and ICH + PBS groups at all time points. (D) vWF expression significantly
decreased in ICH + REP groups relative to ICH-only and ICH + PBS groups (n = 6/group, *p b 0.05, **p b 0.01, ***p b 0.001, scale bar = 100 μm, Tukey's
post-hoc test).
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ischemia. The result of the TTC staining indicates that REP
injected into the rICA, became a self-assembling gel type above
the Tt. However, it did not induce the infarction. However,
further studies on the concentration and amount of REP inducing
cerebral ischemia are required.
As mentioned above, vWF, a 600,000-D to 20,000,000-D
glycoprotein secreted by endothelial cells, is an essential cofactor
associated with the coagulation pathway and plays a crucial role
in promoting the adhesion of platelets to the subendothelial
collagen.49 In the process of coagulation, vWF functions as a
carpet between the exposed endothelial cells and activated
platelets. In addition, vWF, which has an RGD sequence, binds
platelet binding site. Indeed, it has been reported that endothelial
cells are activated and the serum level of vWF is increased upon
traumatic brain injury.27,50,51 In this study, we predicted that
REP injected into the rICA may play an important role as a
carpet, in analogy with the role played by vWF in the damaged
cerebrovessels, thereby attenuating the bleeding in the earlystage of ICH, as well as reducing the expression of vWF.
Consistent with our prediction, the present findings indicate that
the expression of vWF following ICH was significantly reduced
in the REP-treated group as compared to ICH-only and
ICH + PBS groups. However, whether REP interacts with
platelets in the early phase of hemostatsis following ICH is
still unknown and needs further studies.
Furthermore, FAM-labeled REP was specifically located in
the perihematomal parenchyma of the ipsilateral side. A
hyperthermic reaction is spontaneously induced in response to
inflammation, which can be caused by microbial infection as
well as ischemic or hemorrhagic stroke.52–54 We demonstrated
that injected FAM-labeled REP molecules primarily accumulat-
ed in the ruptured vessels of the ipsilateral, but not the
contralateral site. However, the cohesiveness and half-life of
REP according to arterial blood flow must be determined in
future studies. Moreover, the efficiency and the effects of REP
related to the delivery routes (e.g. local injection, intraperitoneal,
intravascular, and oral administration) should be tested in future
Figure 6. Percentage of Iba1-positive microglia in parenchyma lesion after ICH. (A-C) Immunohistochemistry showing the Iba1-positive microglia in the
parenchyma lesion. (D) Activated microglia (% Iba1-positive cell, green) were decreased in ICH + REP groups relative to ICH-only and ICH + PBS groups at
all time points. (n = 5/group, *p b 0.05, **p b 0.01, ***p b 0.001, scale bar = 100 μm, Tukey's post-hoc test.)
1860 J. Park et al / Nanomedicine: Nanotechnology, Biology, and Medicine 13 (2017) 1853–1862research. Additionally, contrary to our prediction that REP may
specifically fill the ruptured part of vessels following ICH,
transformed FAM-labeled REP in vivo was found to be covering
cells located in perihematomal lesion. We speculated that this
phenomenon was caused by the adhesiveness of REP. Finally,
we found that REP improved endothelial cell attachment through
cell adhesion assay. These data support our hypothesis, however,
further studies are needed.
Recently, Jeon and colleagues revealed that infilling wounds
with REP aggregates promotes host cell migration from the
wound margins while enhancing the survival of engrafted
adipose stem cell (ASC) through cell attachment. To better
understand the mechanisms underlying the effects of REP, Jeon
and colleagues measured the activation statuses of Fak, Src, Erk,
and Akt signaling kinases, i.e. kinases that play important roles
in cell adhesion, migration, and survival. Indeed, this mechanis-
tic investigation suggested that the effects of REP are mediated
through the activated Fak/Src signaling and the upregulation of
Mek/Erk and PI3K/Akt survival pathways.10 Therefore, we
speculate that REP may exert its positive effects through the
activation of the same pathway. However, the exact role played
by REP in alleviating the brain damage needs further studies.
In conclusion, here we have shown that the administration of
biosynthesized RGD motif based-REP through the rICA
following ICH specifically covers the ruptured cerebral vessels.
This positive action reduces the hematoma volume, prevents
excessive leakage of blood components from vessels, attenuates
the activation of microglia, and decreases the expression of vWF.
Although the present investigation of REP effects are limited to
the narrow time-window of the acute phase of the rat model of
ICH, REP is a potential therapeutic agent for treating the acutephase IHC due to its non-immunogenicity, biocompatibility,
biodegradability, and the several positive effects described in the
present paper.Acknowledgements
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